Sandoz - Biosimilars http://www.alloftv.com/media-release-topics/biosimilars en Sandoz presents real-world data showing effectiveness of Erelzi? (etanercept-szzs) in rheumatic disease treatment http://www.alloftv.com/news/media-releases/sandoz-presents-real-world-data-showing-effectiveness-erelzi-etanercept-szzs Tue, 12 Nov 2019 07:07:00 +0000 singema2 21981 at http://www.alloftv.com Sandoz announces global deal to commercialize proposed biosimilar natalizumab, a key multiple sclerosis medicine http://www.alloftv.com/news/media-releases/sandoz-announces-global-deal-commercialize-proposed-biosimilar-natalizumab-key Mon, 02 Sep 2019 11:49:05 +0000 singema2 21966 at http://www.alloftv.com Sandoz receives US FDA approval for long-acting oncology supportive care biosimilar ZiextenzoTM (pegfilgrastim-bmez) http://www.alloftv.com/news/media-releases/sandoz-receives-us-fda-approval-long-acting-oncology-supportive-care-biosimilar Fri, 23 Aug 2019 07:55:10 +0000 singema2 21956 at http://www.alloftv.com Sandoz announces first patient enrolled in clinical study for proposed biosimilar denosumab in osteoporosis http://www.alloftv.com/news/media-releases/sandoz-announces-first-patient-enrolled-clinical-study-proposed-biosimilar Mon, 22 Jul 2019 05:55:38 +0000 singema2 21946 at http://www.alloftv.com New Sandoz biosimilar adalimumab data confirms switching from reference biologic has no impact on safety or efficacy http://www.alloftv.com/news/media-releases/new-sandoz-biosimilar-adalimumab-data-confirms-switching-reference-biologic-has Thu, 13 Jun 2019 14:11:31 +0000 singema2 21901 at http://www.alloftv.com Sandoz enters agreement for proposed trastuzumab biosimilar, currently in Phase III development, to treat selected HER2-positive cancer tumors http://www.alloftv.com/news/media-releases/sandoz-enters-agreement-proposed-trastuzumab-biosimilar-currently-phase-iii Wed, 24 Apr 2019 07:28:03 +0000 freixvi1 21881 at http://www.alloftv.com Sandoz receives eighth European Commission approval for a biosimilar with Ziextenzo? (pegfilgrastim) http://www.alloftv.com/news/media-releases/sandoz-receives-eighth-european-commission-approval-biosimilar-ziextenzo Wed, 21 Nov 2018 09:54:00 +0000 singema2 21716 at http://www.alloftv.com Sandoz announces global resolution of biosimilar adalimumab patent disputes, securing patient access http://www.alloftv.com/news/media-releases/sandoz-announces-global-resolution-biosimilar-adalimumab-patent-disputes Wed, 10 Oct 2018 10:02:22 +0000 singema2 21631 at http://www.alloftv.com Sandoz receives positive CHMP opinion for proposed biosimilar pegfilgrastim http://www.alloftv.com/news/media-releases/sandoz-receives-positive-chmp-opinion-proposed-biosimilar-pegfilgrastim Mon, 17 Sep 2018 08:22:45 +0000 singema2 21596 at http://www.alloftv.com Sandoz receives European Commission approval for biosimilar Hyrimoz? (adalimumab) http://www.alloftv.com/news/media-releases/sandoz-receives-european-commission-approval-biosimilar-hyrimozr-adalimumab Fri, 27 Jul 2018 09:56:20 +0000 singema2 21551 at http://www.alloftv.com 92午夜免费福利757-丝袜美腿